跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 11 天前AI 评分33

Stryker 增加董事会席位并选举 James E. Davis 为董事

STRYKER CORP (0000310764) (Filer)

AI 导读

Stryker 于 11 月 3 日将董事会授权人数从 11 人增至 12 人,并选举 James E. Davis 填补新增席位,任命将于 1 月 1 日生效。Davis 现任 Quest Diagnostics 首席执行官兼总裁,并于 2023 年 4 月起担任 Quest 董事会主席;Stryker 表示,他将按其他非雇员董事的标准获得报酬。

正文

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 3, 2026

LOGO

Stryker Corporation

(Exact name of Registrant as Specified in Its Charter)

Michigan   001-13149   38-1239739
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)
1941 Stryker Way
Portage, Michigan
  49002
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (269) 385-2600

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $.10 Par Value   SYK   New York Stock Exchange
2.125% Notes due 2027   SYK27   New York Stock Exchange
3.375% Notes due 2028   SYK28   New York Stock Exchange
0.750% Notes due 2029   SYK29   New York Stock Exchange
2.625% Notes due 2030   SYK30   New York Stock Exchange
1.000% Notes due 2031   SYK31   New York Stock Exchange
3.375% Notes due 2032   SYK32   New York Stock Exchange
3.625% Notes due 2036   SYK36   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 3, 2026, the Board of Directors of Stryker Corporation (the “Company”) increased the number of authorized directors from 11 to 12 and elected James E. Davis to fill the resulting vacancy. Mr. Davis’s election will become effective on January 1, 2027, and he has not been appointed to any committee of the Board at this time.

Mr. Davis has been CEO and President of Quest Diagnostics (“Quest”) since November 2022 and assumed the role of Chairman of the Quest Board in April 2023. Mr. Davis joined Quest in 2013 as Senior Vice President, Diagnostic Services and was named Senior Vice President, Operations in February 2014. Before joining Quest, he served as CEO of InSightec, Inc., a global medical device company. Prior to that, Mr. Davis spent two decades in senior management roles across General Electric’s healthcare and aviation businesses, including five years leading General Electric’s MRI business. Before General Electric, Mr. Davis led the development of strategic and operating initiatives for clients of McKinsey & Company, Inc.

Mr. Davis will be compensated for his services consistent with the Company’s other non-employee directors, as described in the Company’s proxy statement for its 2026 annual meeting of stockholders filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2026. In connection with his election to the Company’s Board of Directors, the Company will enter into the form of indemnification agreement for directors, a copy of which is filed as Exhibit 10(xxviii) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on February 11, 2026, with Mr. Davis.

Item 7.01

Regulation FD Disclosure.

On November 9, 2026, the Company issued a press release announcing the election of Mr. Davis as a director as described in Item 5.02 above, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be incorporated by reference into any filing of the Company, whether made before, on, or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing.

Item 9.01

Financial Statements and Exhibits.

(d)    Exhibits
  

99.1  Press Release dated November 9, 2026.

  

104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    STRYKER CORPORATION
    (Registrant)
Dated: November 9, 2026     By:  

/s/ Tina S. French

    Name:   Tina S. French
    Title:   Corporate Secretary

来源:SEC EDGAR · 本站存档